Literature DB >> 10441075

Retinoid receptors in health and disease: co-regulators and the chromatin connection.

S Minucci1, P G Pelicci.   

Abstract

Retinoid receptors behave as ligand-dependent transcriptional regulators, repressing transcription in the absence of ligand and activating transcription in its presence. The different effects on transcription are carried out through recruitment of co-regulators: unliganded receptors bind corepressors (NCoR and SMRT) that are found within a complex containing histone deacetylase (HDAC) activity, whereas liganded receptors recruit coactivators with histone acetylase activity (HATs). Chromatin remodeling activities have also shown to be required, suggesting a hierarchy of promoter structure modifications in RA target genes carried out by multiple coregulatory complexes. In this review, we examine the experimental evidence for the model just sketched. We focus on recent findings highlighting new molecular details in receptor-coregulator interactions, including the discovery and initial characterisation of novel complexes with multiple chromatin modifying activities. Finally, we look at the role of aberrant recruitment of the NCoRHDAC complex by altered retinoid receptors in the pathogenesis of acute promyelocytic leukemia. These results point to a crucial role for control of transcription factor coregulator interactions in the regulation of cellular processes, and suggest new molecular targets for cancer therapy. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10441075     DOI: 10.1006/scdb.1999.0303

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  25 in total

1.  Targeting protein inactivation through an oligomerization chain reaction.

Authors:  Francesco Contegno; Mario Cioce; Pier Giuseppe Pelicci; Saverio Minucci
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

2.  Impairment of p53 acetylation, stability and function by an oncogenic transcription factor.

Authors:  Alessandra Insinga; Silvia Monestiroli; Simona Ronzoni; Roberta Carbone; Mark Pearson; Giancarlo Pruneri; Giuseppe Viale; Ettore Appella; PierGiuseppe Pelicci; Saverio Minucci
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

3.  Pathological interactions between hematopoietic stem cells and their niche revealed by mouse models of primary myelofibrosis.

Authors:  Lilian Varricchio; Annalisa Mancini; Anna Rita Migliaccio
Journal:  Expert Rev Hematol       Date:  2009-06-01       Impact factor: 2.929

Review 4.  Chapter 5. Nuclear actin-related proteins in epigenetic control.

Authors:  Richard B Meagher; Muthugapatti K Kandasamy; Elizabeth C McKinney; Eileen Roy
Journal:  Int Rev Cell Mol Biol       Date:  2009       Impact factor: 6.813

Review 5.  Regulation of cytochrome P450 (CYP) genes by nuclear receptors.

Authors:  P Honkakoski; M Negishi
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

6.  Signaling disrupts mSin3A binding to the Mad1-like Sin3-interacting domain of TIEG2, an Sp1-like repressor.

Authors:  Volker Ellenrieder; Jin-San Zhang; Joanna Kaczynski; Raul Urrutia
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

7.  A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency.

Authors:  Carl R Walkley; Gemma Haines Olsen; Sebastian Dworkin; Stewart A Fabb; Jeremy Swann; Grant A McArthur; Susan V Westmoreland; Pierre Chambon; David T Scadden; Louise E Purton
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

8.  Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL.

Authors:  Nicole Clarke; Ana M Jimenez-Lara; Emilie Voltz; Hinrich Gronemeyer
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

9.  A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected].

Authors:  Katayoon H Emami; Cu Nguyen; Hong Ma; Dae Hoon Kim; Kwang Won Jeong; Masakatsu Eguchi; Randall T Moon; Jia-Ling Teo; Se Woong Oh; Hak Yeop Kim; Sung Hwan Moon; Jong Ryul Ha; Michael Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

10.  Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiation.

Authors:  Stacey M Frumm; Zi Peng Fan; Kenneth N Ross; Jeremy R Duvall; Supriya Gupta; Lynn VerPlank; Byung-Chul Suh; Edward Holson; Florence F Wagner; William B Smith; Ronald M Paranal; Christopher F Bassil; Jun Qi; Giovanni Roti; Andrew L Kung; James E Bradner; Nicola Tolliday; Kimberly Stegmaier
Journal:  Chem Biol       Date:  2013-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.